{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:02:40Z","timestamp":1775559760513,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":746,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Pfizer Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.vaccine.2011.05.031","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T21:41:19Z","timestamp":1308519679000},"page":"5195-5202","source":"Crossref","is-referenced-by-count":80,"title":["A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged \u226565 years"],"prefix":"10.1016","volume":"29","author":[{"given":"T.F.","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Flamaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C.","family":"R\u00fcmke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Penzes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Juergens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jayawardene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.A.","family":"Emini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.C.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schmoele-Thoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"42","key":"10.1016\/j.vaccine.2011.05.031_bib0005","first-page":"373","article-title":"23-valent pneumococcal polysaccharide vaccine WHO position paper","volume":"83","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.05.031_bib0010","unstructured":"Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 1997; 46(RR-8):1\u201324."},{"key":"10.1016\/j.vaccine.2011.05.031_bib0015","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"1","author":"Moberley","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.031_bib0020","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","article-title":"Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory","volume":"46","author":"de Roux","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2011.05.031_bib0025","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein\u2013polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.05.031_bib0030","series-title":"Active Bacterial Core surveillance (ABCs) report: emerging infections program network: Streptococcus pneumoniae","author":"Centers for Disease Control and Prevention","year":"2005"},{"issue":"16","key":"10.1016\/j.vaccine.2011.05.031_bib0035","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2011.05.031_bib0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1442-200X.2008.02593.x","article-title":"Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults","volume":"50","author":"Scott","year":"2008","journal-title":"Pediatr Int"},{"issue":"33","key":"10.1016\/j.vaccine.2011.05.031_bib0045","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.vaccine.2007.06.004","article-title":"Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults","volume":"25","author":"Scott","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.031_bib0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archinte.1996.00440020115015","article-title":"Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly","volume":"156","author":"Honkanen","year":"1996","journal-title":"Arch Int Med"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.031_bib0055","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.05.031_bib0060","first-page":"378","article-title":"Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults","volume":"66","author":"Hak","year":"2008","journal-title":"Neth J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.031_bib0065","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/CDLI.10.4.514-519.2003","article-title":"Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides","volume":"10","author":"Wernette","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2011.05.031_bib0070","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1086\/322566","article-title":"Analysis of studies to evaluate immune response to combination vaccines","volume":"33","author":"Horne","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2011.05.031_bib0075","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.031_bib0080","series-title":"Note for guidance on harmonisation of requirements for influenza vaccines","author":"The European Agency for the Evaluation of Medicinal Products","year":"1997"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.031_bib0085","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.0006-341X.1999.01202.x","article-title":"Test-based exact confidence intervals for the difference of two binomial proportions","volume":"55","author":"Chan","year":"1999","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.vaccine.2011.05.031_bib0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"13","key":"10.1016\/j.vaccine.2011.05.031_bib0095","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.vaccine.2004.06.047","article-title":"Statistical considerations for vaccine immunogenicity trials Part 2: noninferiority and other statistical approaches to vaccine evaluation","volume":"23","author":"Plikaytis","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2011.05.031_bib0100","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/INF.0b013e3181e075be","article-title":"A phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children","volume":"29","author":"Baxter","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2011.05.031_bib0105","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.vaccine.2009.11.054","article-title":"Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children","volume":"28","author":"Lum","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.031_bib0110","unstructured":"European Influenza Surveillance Scheme. EISS Weekly Electronic Bulletin. Available at: http:\/\/www.eiss.org."},{"issue":"8","key":"10.1016\/j.vaccine.2011.05.031_bib0115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri2368","article-title":"The known unknowns of antigen processing and presentation","volume":"8","author":"Vyas","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2011.05.031_bib0120","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jcpa.2007.04.014","article-title":"The nature and consequences of intra- and inter-vaccine interference","volume":"137","author":"Vidor","year":"2007","journal-title":"J Comp Pathol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T11:22:48Z","timestamp":1592652168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11007420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":24,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0264410X11007420"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}